Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 12
Submit an article Journal homepage
960
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Collagen I enhances the efficiency and anti-tumor activity of dendritic-tumor fusion cells

Jian HeNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Rong ZhengNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Zhenghua ZhangNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Jie TanNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Chaofan ZhouNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Guoqing ZhangNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Xinglu JiangNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Qianyi SunNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Sufang ZhouNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Duo ZhengShenzhen Key Laboratory of Translational Medicine of Tumor, Department of Basic Medicine, School of Medicine, Shenzhen University, Shenzhen, Guangdong, China
,
Yong HuangNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Lige WuNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Zongqiang LaiNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Jieping LiNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Nuo YangNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
,
Xiaoling LuNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, China
&
Yongxiang ZhaoNational Center for International Research of Biological Targeting Diagnosis and Therapy /Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research /Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, Guangxi, ChinaCorrespondence[email protected] [email protected] [email protected]
 show all
Article: e1361094 | Received 22 Mar 2017, Accepted 24 Jul 2017, Published online: 06 Sep 2017

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Shenxia Xie, Xiaoqiong Hou, Wei Yang, Wei Shi, Xiaomei Yang, Siliang Duan, Fengzhen Mo, Aiqun Liu, Wu Wang & Xiaoling Lu. (2021) Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects. International Journal of Nanomedicine 16, pages 6017-6034.
Read now
Rosana Simón-Vázquez, Mercedes Peleteiro & África González-Fernández. (2020) Polymeric nanostructure vaccines: applications and challenges. Expert Opinion on Drug Delivery 17:7, pages 1007-1023.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now

Articles from other publishers (6)

Chunxia Ge, Xuelian YangJiaxuan XinXiangqian GongXuhan WangLijun Kong. (2023) Recent Advances in Antitumor Dendritic Cell Vaccines. Cancer Biotherapy and Radiopharmaceuticals 38:7, pages 450-457.
Crossref
Ximei Xu, Yin Xiang, Yang Yang, Kai Liu, Zhiwei Cui, Xiaodong Tong, Junliang Chen, Fang Hou & Zhiqiang Luo. (2022) The application of tumor cell-derived vesicles in oncology therapy. Clinical and Translational Oncology 25:2, pages 364-374.
Crossref
Jian He, Yu Huo, Zhikun Zhang, Yiqun Luo, Xiuli Liu, Qiaoying Chen, Pan Wu, Wei Shi, Tao Wu, Chao Tang, Huixue Wang, Lan Li, Xiyu Liu, Yong Huang, Yongxiang Zhao, Lu Gan, Bing Wang & Liping Zhong. (2022) Generation of αGal-enhanced bifunctional tumor vaccine. Acta Pharmaceutica Sinica B 12:7, pages 3177-3186.
Crossref
Wei Shi, Xiaomei Yang, Shenxia Xie, Dani Zhong, Xuandong Lin, Ziqiang Ding, Siliang Duan, Fengzhen Mo, Aiqun Liu, Shihua Yin, Xiaobing Jiang, Zhi Ping (Gordon) Xu & Xiaoling Lu. (2021) A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine. Cancer Letters 522, pages 184-197.
Crossref
Yijie Yang, Hongdong Song, Bo Wang, Qi Tian & Bo Li. (2020) A novel di‐peptide Met‐Glu from collagen hydrolysates inhibits platelet aggregation and thrombus formation via regulation of Gq‐mediated signaling. Journal of Food Biochemistry 44:9.
Crossref
Fengzhen Mo, Dabing Xue, Siliang Duan, Aiqun Liu, Xiaomei Yang, Xiaoqiong Hou & Xiaoling Lu. (2019) Novel fusion cells derived from tumor cells expressing the heterologous α-galactose epitope and dendritic cells effectively target cancer. Vaccine 37:7, pages 926-936.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.